FY25 India pharma exports cross $30 billion, surge 31% in March
5 Articles
5 Articles
India’s pharmaceutical exports surge over 9% to reach 30 billion dollars in last financial year - The Indian Awaaz
India’s pharmaceutical exports surpassed 30 billion dollar in the last financial year, with the United States remaining a key market, accounting for more than one-third of the country’s total pharma exports. According to official trade data, pharmaceutical exports reached over 30 billion dollar in Financial Year 2024-25, marking an increase of over 9 per cent compared to nearly 27.5 billion dollar in Financial Year 2023-24. In March 2025, pharma…
Pharmaceutical exports from India cross $30 billion FY25 | DH NEWS, DH Latest News, Latest News, India, NEWS , pharmaceutical, Pharmaceutical exports
New Delhi: India’s pharmaceutical exports surpassed $30 billion in the last financial year of 2024-25. This is an increase of over 9 per cent compared to nearly $27.5 billion in financial year 2023-24. In March 2025, pharma exports registered a year-on-year surge of over 30 per cent, rising to $3,681 million from $2,806 million dollar in the same month of the previous fiscal. The next best performance during the fiscal came in January when the e…
India's pharma exports surpass $30 billion in FY25, US top market
In a significant achievement, the pharmaceutical exports from India crossed $30 billion in the last financial year (FY25), with the US remaining as a key market with more than one-third of the country's pharma exports.
India’s pharma exports surpass $30 billion in FY25, US top market...
Last Updated on April 19, 2025 by Team THIP New Delhi, April 19 (IANS) In a significant achievement, the pharmaceutical exports from India crossed $30 billion in the last financial year (FY25), with the US remaining as a key market with more than one-third of the country’s pharma exports. According to official trade data, the […] The post India’s pharma exports surpass $30 billion in FY25, US top market appeared first on THIP Media.
Coverage Details
Bias Distribution
- 100% of the sources lean Left
To view factuality data please Upgrade to Premium
Ownership
To view ownership data please Upgrade to Vantage